Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in AMGN — Amgen Inc

CIK 873630 LONDON, X0
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$501,652,433
+$26,181,000 QoQ
Shares Held
1,385,321
+2.5% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#45
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Jun 30, 2026
CallValue
$9,197,848
CallShares
25,400
PutValue
$17,381,760
PutShares
48,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $8,561,718,221 across 13 Drug Manufacturers - General names. AMGN ranks #5 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 1,988,595 $2,385,180,690
2 JNJ
Johnson & Johnson
 9,006,497 $2,287,380,035
3 ABBV
AbbVie Inc.
 4,131,637 $1,039,685,126
4 MRK
Merck & Co., Inc.
 7,734,965 $993,943,001
5 AMGN
Amgen Inc
This page 		1,385,321 $501,652,433
6 GILD
Gilead Sciences, Inc.
 3,836,489 $484,702,016
7 PFE
Pfizer Inc
 16,704,156 $402,236,070
8 BMY
Bristol Myers Squibb Co
 5,409,898 $311,718,319

All Filings in AMGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,381,760 48,000
2026-06-30 $9,197,848 25,400
2026-06-30 $501,652,433 1,385,321
2026-03-31 $23,433,210 66,600
2026-03-31 $475,471,433 1,351,347
2026-03-31 $7,494,405 21,300
2025-12-31 $503,157,614 1,537,251
2025-12-31 $4,287,761 13,100
2025-12-31 $130,924 400
2025-09-30 $402,669,482 1,426,894
2025-06-30 $311,543,068 1,115,802
2025-03-31 $383,636,741 1,231,381
2025-03-31 $996,960 3,200
2024-12-31 $21,007,584 80,600
2024-12-31 $7,793,136 29,900
2024-12-31 $360,224,541 1,382,077
2024-09-30 $9,601,858 29,800
2024-09-30 $15,466,080 48,000
2024-09-30 $498,012,597 1,545,615
2024-06-30 $4,311,810 13,800
2024-06-30 $589,769,674 1,887,565
2024-06-30 $14,997,600 48,000
2024-03-31 $17,798,432 62,600
2024-03-31 $10,008,064 35,200
2024-03-31 $478,119,046 1,681,623
2023-12-31 $12,644,078 43,900
2023-12-31 $34,072,766 118,300
2023-12-31 $422,826,319 1,468,045
2023-09-30 $18,141,300 67,500
2023-09-30 $336,341,581 1,251,457
2023-09-30 $2,848,856 10,600
2023-06-30 $356,998,609 1,607,957
2023-06-30 $14,697,724 66,200
2023-06-30 $2,353,412 10,600
2023-03-31 $18,880,675 78,100
2023-03-31 $338,812,380 1,401,499
2023-03-31 $38,680 160
2023-03-31 $4,037,225 16,700
2022-12-31 $42,757,792 162,800
2022-12-31 $324,188,103 1,234,344
2022-12-31 $42,022 160
2022-12-31 $11,372,312 43,300
2022-09-30 $191,372,260 849,034
2022-09-30 $31,172,820 138,300
2022-09-30 $10,278,240 45,600
2022-06-30 $220,436,121 906,026
2022-06-30 $24,962,580 102,600
2022-06-30 $10,315,920 42,400
2022-03-31 $232,458,418 961,287
2022-03-31 $6,843,506 28,300

Report a Problem

Category
Description
Email (optional, for follow-up)